A collaboration of researchers in Switzerland, Germany, and the US tracked cardiac function in recreational marathon runners ...

Home Articles Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the Cardiac and Metabolic Effects of Dapagliflozin ...

Robot-assisted training with a lightweight exosuit may help patients with advanced heart failure walk more and help them stay ...

Among patients with heart failure with preserved ejection fraction (HFpEF), lower versus higher ranges of EF signal fundamentally different morphologies and hemodynamic responses, which may have ...

A new study published in the Journal of American Medical Association showed that reduced right ventricular ejection fraction ...

Tenax Therapeutics ($TENX) announced an update on their ongoing clinical study. Tenax Therapeutics (TENX) is actively recruiting participants for ...

Some elite endurance athletes have evidence of impaired cardiac function, which, along with other findings, may raise suspicions of early dilated cardiomyopathy, according to results of a new study.

For decades, physicians had little to offer patients who have heart failure with preserved ejection fraction (HFpEF), which is a growing global health problem with a grim death rate in the 5 years ...

An overview of the PARAGON-HF trial with special consideration to the rationale behind the design, the cardiovascular end points, and the safety profile. John McMurray, MBChB: The most recent attempt ...

Jim Januzzi, MD, outlines a multitude of drug treatment options for heart failure revolving around patient ejection fraction (EF) status. Ryan Haumschild, PharmD, MS, MBA: As we start to transition ...

Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ...